arrow
S

Shinichi Aishima

kyushu university
H指数:48
被引数:7,416

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nuclear Pan-Lysine Lactylation Immunoreactivity Is Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma

核泛赖氨酸乳酰化免疫反应性与肝内胆管癌的不良预后相关

2026-09-080
PRE
PRSS1 A16V germline mutation is common in a cohort of intraductal papillary mucinous neoplasms of the pancreas

PRSS1 A16V种系突变在胰腺导管内乳头状黏液性肿瘤队列中常见

Surgery
IF2.7
2026-08-010
PRE
Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis

基于体成分分析的代谢功能障碍相关脂肪性肝病的肝脏脂肪变量化评估

2025-08-300
OAAI
A Noninvasive Method of Diagnosing Metabolic Dysfunction-Associated Steatohepatitis Using Cytokeratin-18 Fragment and FIB-3 Index

一种利用细胞角蛋白-18片段和FIB-3指数诊断代谢功能障碍相关脂肪性肝炎的非侵入性方法

2025-04-170
OA
Accuracy of type IV collagen 7S versus Enhanced Liver Fibrosis score for diagnosing fibrosis in patients with metabolic dysfunction-associated steatotic liver disease

IV型胶原7s与增强肝纤维化评分诊断代谢功能障碍相关脂肪性肝病患者纤维化的准确性

2025-01-010
OAAI
Validation study of age-independent fibrosis score (Fibrosis-3 index) in patients with metabolic dysfunction-associated steatotic liver disease

与年龄无关的纤维化评分 (纤维化-3指数) 在代谢功能障碍相关的脂肪性肝病患者中的验证研究

2024-04-252
PRE
Hepatic inflammation and fibrosis are profiles related to mid-term mortality in biopsy-proven MASLD: A multicenter study in Japan
2024-04-232
PRE
Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications
2024-04-016
OAAI
Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study

活检证实的代谢功能障碍相关的脂肪性肝病的预后: cllione研究的子分析

2024-04-0110
OAAI
Identification of clinical phenotypes associated with poor prognosis in patients with nonalcoholic fatty liver disease via unsupervised machine learning
2023-08-191
PRE
M-PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis
2023-06-155
OA
Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease
2023-04-228
OAAI
Noninvasive tests predict liver-related events and mortality in patients with nonalcoholic fatty liver disease: sub-analysis of the CLIONE-Asia study

非侵入性检测可预测非酒精性脂肪肝患者的肝脏相关事件和死亡率: clione-asia研究的子分析

2023-03-161
PRE
Validation of the utility of Agile scores to identify advanced fibrosis and cirrhosis in Japanese patients with nonalcoholic fatty liver disease
2023-03-077
PRE
Multicenter, retrospective, cohort study shows platelet counts predict hepatocellular carcinoma development in patients with nonalcoholic fatty liver disease
2023-02-176
PRE